Fortrea Holdings/FTRE

$36.21

-0.82%
-
1D1W1MYTD1YMAX

About Fortrea Holdings

Fortrea Holdings Inc. is a global contract research organization (CRO). The Company is providing clinical development, patient access solutions and consulting to the life sciences industry. The Company provides phase I through IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. The Company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment offers solutions to the market that include clinical pharmacology and comprehensive clinical development capabilities. Its Enabling Services segment provides patient access and technology solutions that can be deployed as a standalone offering or across its global solutions depending on the scope of its customers’ needs. The Company offers its customers with clinical trial solutions through three delivery models: Full Service, Functional Service Provider, and Hybrid.

Ticker

FTRE

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

-

Employees

18,000

Headquarters

Durham, United States

Website

-

Fortrea Holdings Metrics

BasicAdvanced
$3.4B
Market cap
-
P/E ratio
-$0.04
EPS
-
Beta
-
Dividend rate
$3.4B
$41.02
$24.93
819.44K
1.615
90.056
91.557
92.66
1.27%
1.094
1.943
26.749
0.42%
-101.74%
6.41%

What the Analysts think about Fortrea Holdings

Analyst Ratings

Majority rating from 7 analysts.
Buy

Price Targets

Average projection from 6 analysts.
11.85% upside
High $45.00
Low $33.00
$36.21
Current price
$40.50
Average price target

Fortrea Holdings Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-4.64% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$775.4M
-0.13%
Net income
$-36M
174.81%
Profit margin
-4.64%
176.19%

Fortrea Holdings Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 20.67%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Actual
$0.24
$0.19
-
Expected
$0.16
$0.24
$0.01
Surprise
48.84%
-20.67%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Fortrea Holdings stock?

Fortrea Holdings (FTRE) has a market cap of $3.4B as of April 18, 2024.

What is the P/E ratio for Fortrea Holdings stock?

The price to earnings (P/E) ratio for Fortrea Holdings (FTRE) stock is 0 as of April 18, 2024.

Does Fortrea Holdings stock pay dividends?

No, Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders as of April 18, 2024.

When is the next Fortrea Holdings dividend payment date?

Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders.

What is the beta indicator for Fortrea Holdings?

Fortrea Holdings (FTRE) does not currently have a Beta indicator.

What is the Fortrea Holdings stock price target?

The target price for Fortrea Holdings (FTRE) stock is $40.5, which is 11.85% above the current price of $36.21. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Fortrea Holdings stock

Buy or sell Fortrea Holdings stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing